Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis

Lupus

Volumn 7, Issue 6, 1998, Pages 387-391

  Miranda, J M ^a   Prieto, R E ^a   Paniagua, R ^a   Garcia, G ^a   Amato, D ^a   Barile, L ^a   Jara, L J ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Glomerulonephritis; Prolactin; Systemic lupus erythematosus

Indexed keywords

COMPLEMENT; CREATININE; CYCLOPHOSPHAMIDE; DNA ANTIBODY; PREDNISONE; PROLACTIN;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HORMONE URINE LEVEL; HUMAN; HYPERPROLACTINEMIA; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NEPHELOMETRY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TIME; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; HUMANS; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROLACTIN;

EID: 0031661699     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678920307     Document Type: Conference Paper

References (23)

1. Besedosvsky HO, Del Rey A. Immuno-neuro-endocrine interactions: facts and hypothesis. Endocr Rev 1996, 64-102.
2. Berczi Y, Nagy E. The effect of prolactin and growth hormone on hemolymphopoietic tissue and immune function. In: Berczi Y, Kovacs K (eds) Hormones and immunity MTP Press: Lancaster 1987; p 145.
3. Buskila D, Sukrenik S, Shoenfeld Y. The possible role of prolactin in autoimmunity. Am J Reprod Immunol 1991; 26: 118-123.
4. Walker SE, Allen SH, Huffman, RW, McMurray RW Prolactin: a stimulator of disease activity in systemic lupus erythematosus. Lupus 1995; 4: 3-9.
5. Jara-Quezada L, Graef A, Lavalle C. Prolactin and hormones during pregnancy in systemic lupus erythematosus. J Rheumatol 1991; 18: 349-353.
6. Jara LJ et al. Hyperprolactinemia in systemic lupus erythematosus (SLE): association with disease activity. Am J Med Sci 1992; 303: 222-226.
7. Neidhart M. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune process in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 1996; 23: 476-481.
8. Buskila D et al. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatolo 1996; 23: 269-272.
9. Pauzner R et al. Prolactin in systemic lupus erythematosus. J Rheumatol 1994; 21: 2064-2067.
10. McMurray R et al. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 1991; 147: 3780-3787.
11. McMurray R et al. Hyperprolactinemia in male NZB/NZW (B/W) F1 mice, accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol 1994; 71: 1143-1151
12. Russel DH et al. Prolactin receptors on human T and B lymphocytes, antagonism of prolactin binding by cyclosporine. J Immunol 1985; 134: 3027-3031
13. Houghe R, Delhase M, Vezgani P. Growth hormone and prolactin are paracrinc growth and differentiation factors in the haemopoietic system. Immunol Today 1993; 14: 212-214.
14. Larrea F et al. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J Clin Endocrinol Metabol 1997; 82: 3664-3669
15. Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
16. Appel GB et al. Renal involvement in systemic lupus erythematosus. A study of 56 patients emphasizing histologic classification. Medicine 1983; 75: 382-389.
17. Austin HA et al. Prognostic factors in lupus nephritis: contribution of renal histopathologic data. Am J Med 1983; 75: 383-388.
18. Iwano M et al Urinary levels of IK-6 in patients with active lupus nephritis Clin Nephrology 1993; 40: 16-21.
19. Spangelo BN, Hall N, Ross PC, Goldstein A. Stimulation of in vivo antibody production and concanavalin-A-induced mouse spleen cells mitogenesis by prolactin. Immunopharmacology 1987; 14: 11-20.
20. McMurray RW, Hoffman R, Walker SE. In vivo prolactin manipulations alters in vitro IL-2, IL-4, and IFN mRNA levels in female B/W mice (abstr). Clin Res 1991; 39: p 734.
21. Gutierrez ME et al. Prolactin-induced immunoglobulin and autoantibody production by peripheral blood monouclear cells from systemic lupus erythematosus and normal individuals. Int Arch Allergy Immunol 1996; 109: 229-235
22. Gutiérrez MA et al. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus 1995; 4: 348-352.
23. Jara LJ et al. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol 1998 (in press).